| Brittany Nicole Bryan, | |
|
1445 N 7th St, Manitowoc, WI 54220-2011 | |
| (920) 682-0314 | |
| Not Available |
| Full Name | Brittany Nicole Bryan |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 5 Years |
| Location | 1445 N 7th St, Manitowoc, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053947283 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 673726 (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fox Rehabilitation Services Of South Carolina, Llc | 3971639998 | 209 |
News Archive
Thanks to a quirk in the way our brain evaluates goals, people feel it's easier to achieve a small incremental goal than to maintain the status quo, when both goals are assessed in isolation. This is especially true if the context is seen as unfavourable.
A group of researchers from several institutions in the USA, including Johns Hopkins Medicine, reports that its review of 22 clinical trials of fragile X syndrome (FXS) suggests the need for a wider use of newer and improved treatment outcome measurement tools for this and other several neurodevelopmental disorders.
BioDelivery Sciences International, Inc. today announced a positive End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) which took place on September 14, 2010. At that meeting, agreement was reached on the BEMA Buprenorphine development plan for the treatment of chronic pain.
Following the provision of clinical and scientific data to the US Food and Drug Administration (FDA), privately owned UK company Daval International Limited (http://www.davalinternational.com) has been informed that its innovative anti-inflammatory agent AIMSPRO(R) has been awarded an Orphan-Drug designation for the treatment of Amyotrophic Lateral Sclerosis (ALS).
A new study reveals that the US has experienced widespread adoption of robot-assisted prostate removal surgery to treat prostate cancer in recent years. The BJU International study also found that while such surgeries are more expensive than traditional surgeries, their costs are decreasing over time.
› Verified 7 days ago
| Provider Name | Fox Rehabilitation Services Of South Carolina, Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1902133689 PECOS PAC ID: 3971639998 Enrollment ID: O20100330000294 |
News Archive
Thanks to a quirk in the way our brain evaluates goals, people feel it's easier to achieve a small incremental goal than to maintain the status quo, when both goals are assessed in isolation. This is especially true if the context is seen as unfavourable.
A group of researchers from several institutions in the USA, including Johns Hopkins Medicine, reports that its review of 22 clinical trials of fragile X syndrome (FXS) suggests the need for a wider use of newer and improved treatment outcome measurement tools for this and other several neurodevelopmental disorders.
BioDelivery Sciences International, Inc. today announced a positive End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) which took place on September 14, 2010. At that meeting, agreement was reached on the BEMA Buprenorphine development plan for the treatment of chronic pain.
Following the provision of clinical and scientific data to the US Food and Drug Administration (FDA), privately owned UK company Daval International Limited (http://www.davalinternational.com) has been informed that its innovative anti-inflammatory agent AIMSPRO(R) has been awarded an Orphan-Drug designation for the treatment of Amyotrophic Lateral Sclerosis (ALS).
A new study reveals that the US has experienced widespread adoption of robot-assisted prostate removal surgery to treat prostate cancer in recent years. The BJU International study also found that while such surgeries are more expensive than traditional surgeries, their costs are decreasing over time.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brittany Nicole Bryan, 1445 N 7th St, Manitowoc, WI 54220-2011 Ph: () - | Brittany Nicole Bryan, 1445 N 7th St, Manitowoc, WI 54220-2011 Ph: (920) 682-0314 |
News Archive
Thanks to a quirk in the way our brain evaluates goals, people feel it's easier to achieve a small incremental goal than to maintain the status quo, when both goals are assessed in isolation. This is especially true if the context is seen as unfavourable.
A group of researchers from several institutions in the USA, including Johns Hopkins Medicine, reports that its review of 22 clinical trials of fragile X syndrome (FXS) suggests the need for a wider use of newer and improved treatment outcome measurement tools for this and other several neurodevelopmental disorders.
BioDelivery Sciences International, Inc. today announced a positive End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) which took place on September 14, 2010. At that meeting, agreement was reached on the BEMA Buprenorphine development plan for the treatment of chronic pain.
Following the provision of clinical and scientific data to the US Food and Drug Administration (FDA), privately owned UK company Daval International Limited (http://www.davalinternational.com) has been informed that its innovative anti-inflammatory agent AIMSPRO(R) has been awarded an Orphan-Drug designation for the treatment of Amyotrophic Lateral Sclerosis (ALS).
A new study reveals that the US has experienced widespread adoption of robot-assisted prostate removal surgery to treat prostate cancer in recent years. The BJU International study also found that while such surgeries are more expensive than traditional surgeries, their costs are decreasing over time.
› Verified 7 days ago
Brittney Nicole Lapalme, MOTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1650 S 41st St, Manitowoc, WI 54220 Phone: 920-320-3100 Fax: 920-320-5114 | |
Mrs. Heather Nicole Reinemann, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2021 S Alverno Rd, Manitowoc Health & Rehab Center, Manitowoc, WI 54220 Phone: 920-683-4592 | |
Vickie Patricia Mullins, OTR / CHT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 920 State St, Manitowoc, WI 54220 Phone: 920-683-1900 | |
Mrs. Crystal Schenian, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1445 N 7th St, Manitowoc, WI 54220 Phone: 920-682-0314 Fax: 920-683-0210 | |
Mrs. Hailey Dawn Hageness, M.S.O.T., OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1235 S 24th St, Attn Rehabcare, Manitowoc, WI 54220 Phone: 920-682-8254 | |
Ms. Brianna Schad, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9629 Old 151 Rd, Manitowoc, WI 54220 Phone: 920-323-9043 |